介入治疗早已成为冠心病的主要治疗手段之一,2004年仅美国本土就完成介入治疗100万余例[1],有资料显示其中85%是针对稳定型心绞痛患者[2]。我国的年介入治疗例数也早已突破10万例。研究发现,介入治疗能降低急性冠状动脉综合征患者的死亡率和心肌梗死发生率,改善其预后[3-6],而 Interventional therapy has long been one of the main treatments for coronary heart disease. In 2004, only 1 million cases of interventional treatment were completed in the United States [1]. There are data showing that 85% of them are for stable angina pectoris [2]. China’s annual number of interventional treatment has also exceeded 100,000 cases. The study found that interventional therapy can reduce mortality and myocardial infarction in patients with acute coronary syndrome and improve their prognosis [3-6], while